2023
DOI: 10.3389/fmicb.2023.1173042
|View full text |Cite
|
Sign up to set email alerts
|

Off-label use of antimicrobials among hospitalized children: a retrospective study of 3,406 patients

Abstract: IntroductionOff-label drug use is a global problem for which many countries and regions have issued legal provisions or reached an expert consensus. Off-label use is sometimes a necessity, especially since antibacterial drugs have become one of the most widely used drugs in pediatric settings and the issue of causing antimicrobial resistance has increasingly become unavoidable. It also poses additional risks, such as adverse drug reactions.MethodsOur study analyzed the antimicrobial prescriptions of pediatric … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…There should be a specialised approach to managing off-label medication as the risk of antibiotic resistance is rising globally. 32 Additionally, The use of third-generation cephalosporins is sharply increasing in the paediatric population, which, in light of the statement above, maybe the root of the emergence of resistance. Third-generation cephalosporin usage is ubiquitous, which aids in the development and spread of bacterial infections that produce ESBL.…”
Section: Discussionmentioning
confidence: 99%
“…There should be a specialised approach to managing off-label medication as the risk of antibiotic resistance is rising globally. 32 Additionally, The use of third-generation cephalosporins is sharply increasing in the paediatric population, which, in light of the statement above, maybe the root of the emergence of resistance. Third-generation cephalosporin usage is ubiquitous, which aids in the development and spread of bacterial infections that produce ESBL.…”
Section: Discussionmentioning
confidence: 99%
“…In case of vancomycin, steady-state trough concentration (C 0 ) and area under the steady-state curve (AUC 0-24 ) targets are often used for dose optimization of vancomycin. C 0 -based and AUC 0-24 -based machine learning models of vancomycin have been successfully developed and can achieve individualized initial dose prediction and further optimization based on therapeutic drug monitoring results in neonates by accurately predicting C 0 and AUC 0-24 ( Tang L et al, 2023 ).…”
Section: Model-based Evaluation Of Antimicrobial Agents In Children: ...mentioning
confidence: 99%
“…Due to a lack of sufficient information on children’s medication on drug labels and difficulties in conducting clinical trials [ 1 , 2 ], off-label prescribing in children is common globally and in China [ 3 ]. Overall, the off-label prescribing rates in children ranged from 46.9 to 98.1% in China [ 1 , 4 10 ], 53.0–98.1% in neonates [ 1 , 5 , 6 ], 57.2–82.7% in outpatients [ 7 , 8 ] and 48.9–79.0% [ 9 , 10 ] in inpatients; thus, increased risks related to treatment and legal practices exist in the treatment of children’s diseases [ 4 ]. In addition to drug labels, clinical treatment guidelines and expert consensuses based on clinical research have become the main sources and basis of physicians’ medication evidence [ 11 ], especially paediatricians, and the clinical research evidence in the guidelines and expert consensuses are generally graded according to the research design type.…”
Section: Introductionmentioning
confidence: 99%